fluorodeoxyglucose f18 has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, X; Wang, W; Yang, J; Zhou, Z | 1 |
| Alvaro, PR; Atri Moises, M; Feregrino Rodrigo, R; Montell García, M; Moreno Manlio Gerardo, G; Romero Cabello, R; Romero Feregrino, R; Trejo Estrada, R | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Acute Hepatic Failure
| Article | Year |
|---|---|
Angiosarcoma of the liver as a cause of fulminant liver failure.
Topics: Aged; Fatal Outcome; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Immunohistochemistry; Liver Failure, Acute; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
1 other study(ies) available for fluorodeoxyglucose f18 and Acute Hepatic Failure
| Article | Year |
|---|---|
Hepatic Angiosarcoma With Diffuse Increased 18 F-FDG Uptake on PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Liver Failure, Acute; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |